Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AmerisourceBergen    ABC

AMERISOURCEBERGEN

(ABC)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/10/2019 06/11/2019 06/12/2019 06/13/2019 06/14/2019 Date
84.77(c) 84.72(c) 85.38(c) 86.44(c) 85.05(c) Last
1 418 037 1 253 902 1 135 964 1 022 718 1 003 671 Volume
+1.55% -0.06% +0.78% +1.24% -1.61% Change
More quotes
Financials (USD)
Sales 2019 179 B
EBIT 2019 2 021 M
Net income 2019 869 M
Debt 2019 1 515 M
Yield 2019 1,92%
Sales 2020 188 B
EBIT 2020 2 113 M
Net income 2020 1 351 M
Debt 2020 1 196 M
Yield 2020 1,99%
P/E ratio 2019 21,45
P/E ratio 2020 12,81
EV / Sales2019 0,11x
EV / Sales2020 0,10x
Capitalization 17 546 M
More Financials
Company
AmerisourceBergen specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The... 
Sector
Drug Retailers
Calendar
08/01Earnings Release
More about the company
Surperformance© ratings of AmerisourceBergen
Trading Rating : Investor Rating :
More Ratings
Latest news on AMERISOURCEBERGEN
06/07AMERISOURCEBERGEN : LUGPA Launches Benchmarking Program in Collaboration with In..
PU
05/28GENERAL ELECTRIC : GE Healthcare and World Courier collaborate to drive commerci..
AQ
05/20AMERISOURCEBERGEN CORP : Other Events (form 8-K)
AQ
05/17AMERISOURCEBERGEN : Ex-dividend day for
FA
05/16AMERISOURCEBERGEN : World Courier Enhances Distribution Capabilities & Customer ..
AQ
05/08AMERISOURCEBERGEN : Declares Quarterly Dividend
BU
05/02AMERISOURCEBERGEN : Management's Discussion and Analysis of Financial Condition ..
AQ
05/02AMERISOURCEBERGEN : Fiscal 2Q Earnings Snapshot
AQ
05/02AMERISOURCEBERGEN CORP : Results of Operations and Financial Condition, Regulati..
AQ
05/02AMERISOURCEBERGEN : Reports Fiscal 2019 Second Quarter ResultsLearn More
PU
More news
Analyst Recommendations on AMERISOURCEBERGEN
More recommendations
Sector news : Drug Retailers - NEC
06/14Change Healthcare Sets IPO at 42.9 Million Shares; Sees Pricing at $16-$19 Ap..
DJ
06/12U.S. pet doctors steel themselves for online pharmacy challenge
RE
06/11Kroger to start selling cannabis-based products
RE
05/21KROGER : Loop Launches in U.S., Announces Kroger and Walgreens as Founding Retai..
DJ
05/08Walmart raises U.S. tobacco purchase age to 21 starting in July
RE
More sector news : Drug Retailers - NEC
Chart AMERISOURCEBERGEN
Duration : Period :
AmerisourceBergen Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMERISOURCEBERGEN
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 87,7 $
Spread / Average Target 5,0%
EPS Revisions
Managers
NameTitle
Steven H. Collis Chairman, President & Chief Executive Officer
James Francis Cleary Chief Financial Officer & Executive Vice President
Dale B. Danilewitz Chief Information Officer & Executive VP
Henry Wadsworth McGee Independent Director
Jane Ellen Henney Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
AMERISOURCEBERGEN14.31%16 892
WALGREENS BOOTS ALLIANCE-22.60%45 633
MCKESSON CORPORATION20.51%23 662
CARDINAL HEALTH-0.99%12 793
SINOPHARM HOLDING CO LTD-17.02%11 235
SHANGHAI PHARMACEUTICALS HOLDING CO LTD4.12%6 953